Pure Biologics S.A. (FRA:PQB)
0.7425
-0.0215 (-2.81%)
At close: Jan 30, 2026
Pure Biologics Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
6
Market Cap
10.82M EUR
Revenue Chart
* This company reports financials in PLN.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 662.00K | 408.00K | 160.63% |
| Dec 31, 2021 | 254.00K | -318.00K | -55.59% |
| Dec 31, 2020 | 572.00K | -1.20M | -67.79% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Turbon AG | 54.96M |
| MedNation AG | 49.96M |
| plenum AG | 29.42M |
| Park & Bellheimer AG | 25.32M |
| Erlebnis Akademie AG | 24.95M |
| Regenbogen AG | 21.90M |
| Beyond Frames Entertainment AB | 15.67M |
| Your Family Entertainment AG | 2.62M |